全文获取类型
收费全文 | 31203篇 |
免费 | 2360篇 |
国内免费 | 58篇 |
专业分类
耳鼻咽喉 | 276篇 |
儿科学 | 882篇 |
妇产科学 | 925篇 |
基础医学 | 3826篇 |
口腔科学 | 370篇 |
临床医学 | 4186篇 |
内科学 | 6305篇 |
皮肤病学 | 543篇 |
神经病学 | 3039篇 |
特种医学 | 680篇 |
外科学 | 3695篇 |
综合类 | 344篇 |
一般理论 | 51篇 |
预防医学 | 3626篇 |
眼科学 | 656篇 |
药学 | 2022篇 |
1篇 | |
中国医学 | 31篇 |
肿瘤学 | 2163篇 |
出版年
2023年 | 275篇 |
2022年 | 369篇 |
2021年 | 972篇 |
2020年 | 602篇 |
2019年 | 999篇 |
2018年 | 1064篇 |
2017年 | 771篇 |
2016年 | 775篇 |
2015年 | 885篇 |
2014年 | 1229篇 |
2013年 | 1673篇 |
2012年 | 2409篇 |
2011年 | 2420篇 |
2010年 | 1335篇 |
2009年 | 1069篇 |
2008年 | 1853篇 |
2007年 | 1984篇 |
2006年 | 1735篇 |
2005年 | 1729篇 |
2004年 | 1546篇 |
2003年 | 1357篇 |
2002年 | 1240篇 |
2001年 | 415篇 |
2000年 | 390篇 |
1999年 | 356篇 |
1998年 | 261篇 |
1997年 | 201篇 |
1996年 | 176篇 |
1995年 | 125篇 |
1994年 | 117篇 |
1993年 | 116篇 |
1992年 | 188篇 |
1991年 | 186篇 |
1990年 | 226篇 |
1989年 | 171篇 |
1988年 | 192篇 |
1987年 | 171篇 |
1986年 | 198篇 |
1985年 | 169篇 |
1984年 | 114篇 |
1983年 | 111篇 |
1982年 | 77篇 |
1980年 | 77篇 |
1979年 | 140篇 |
1978年 | 92篇 |
1977年 | 81篇 |
1976年 | 76篇 |
1973年 | 69篇 |
1972年 | 76篇 |
1971年 | 67篇 |
排序方式: 共有10000条查询结果,搜索用时 562 毫秒
61.
62.
63.
Michelle K Nurzenski N Kathryn Briffa Roger I Price Benjamin C C Khoo Amanda Devine Thomas J Beck Richard L Prince 《Journal of bone and mineral research》2007,22(3):416-424
A population-based study on 1008 postmenopausal women identified that the 24% of women achieving high levels of PA and CI had 3.4-4.4% higher femoral bone strength in axial compression and 1.7-5.2% in bending than those achieving low levels, indicating that lifestyle factors influence bone strength in the proximal femur. INTRODUCTION: Extensive research has shown that increased physical activity (PA) and calcium intake (CI) decrease the rate of bone loss; however, there is little research on how these lifestyle variables affect bone geometry. This study was designed to investigate the effects of modifiable lifestyle variables, habitual PA and dietary CI, on femoral geometry in older women. MATERIALS AND METHODS: Femoral geometry, habitual PA, and dietary CI were measured in a population-based sample of 1008 women (median age+/-interquartile range, 75+/-4years) enrolled in a randomized controlled trial (RCT) of calcium supplementation. Baseline PA and CI were assessed by validated questionnaires, and 1-year DXA scans (Hologic 4500A) were analyzed using the hip structural analysis technique. Section modulus (Z), an index of bending strength, cross-sectional area (CSA), an index of axial compression strength, subperiosteal width (SPW), and centroid position, the position of the center of mass, were measured at the femoral neck (NN), intertrochanter (IT), and femoral shaft (FS) sites. These data were divided into tertiles of PA and CI, and the results were compared using analysis of covariance (ANCOVA), with corrections for age, height, weight, and treatment (calcium/placebo). RESULTS AND CONCLUSIONS: PA showed a significant dose-response effect on CSA all hip sites (p<0.03) and Z at the narrow neck and intertrochanter sites (p<0.02). For CI, there was a dose-response effect for centroid position at the intertrochanter (p=0.03). These effects were additive, such that the women (n=240) with PA in excess of 65.5 kcal/day and CI in excess of 1039 mg/day had significantly greater CSA (NN, 4.4%; IT, 4.3%; FS, 3.4%) and Z (NN, 3.9%; IT, 5.2%). These data show a favorable association between PA and aspects of bone structural geometry consistent with better bone strength. Association between CI and bone structure was only evident in 1 of 15 variables tested. However, there was evidence that there may be additive effects, whereby women with high levels of PA and CI in excess of 1039 mg/day had significantly greater CSA (NN, 0.4%; FS, 2.1%) and Z (IT, 3.0%) than women with high PA but low CI. These data show that current public health guidelines for PA and dietary CI are not inappropriate where bone structure is the health component of interest. 相似文献
64.
Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair. 总被引:4,自引:0,他引:4
Negin Amanat Michelle McDonald Craig Godfrey Lynne Bilston David Little 《Journal of bone and mineral research》2007,22(6):867-876
We hypothesized that ZA treatment would bolster fracture repair. In a rat model for closed fracture healing, a single dose of ZA at 0, 1, or 2 wk after fracture significantly increased BMC and strength of the healed fracture. Delaying the dose (1 or 2 wk after fracture) displayed superior results compared with dosing at the time of fracture. INTRODUCTION: Bisphosphonates are known to increase bone strength and thus the resistance to fracture by decreasing osteoclastic bone resorption. These properties may enable bisphosphonates to also increase the strength of fracture repair. Zoledronic acid (ZA) is a potent bisphosphonate with a high affinity for bone mineral, allowing bolus intravenous dosing in a range of indications. In this study, we examined the application of bolus dose ZA in endochondral fracture repair. MATERIALS AND METHODS: Carbon-14 labeled ZA was used in a closed rat fracture model. Rats were divided into five treatment groups (n = 25 per group): saline control, local ZA (0.01 mg/kg), and three systemic bolus ZA groups (0.1 mg/kg) with different administration times: at fracture, 1 wk after fracture, and 2 wk after fracture. Rats were killed 6 wk postoperatively. Postmortem analyses included radiography, QCT, microCT, biomechanical testing, scintillation counting, autoradiography, and histology. RESULTS: Single-dose systemic ZA administration significantly increased callus volume, callus BMC, and mechanical strength. Perioperative treatment increased mechanical strength by 30% compared with controls (p < 0.05). Administering the systemic dose at 1 or 2 wk after fracture further increased mechanical strength compared with controls by 44% and 50%, respectively (p < 0.05). No significant differences in mechanical parameters were seen with local injection at the dose studied. Autoradiographic analysis indicated that ZA binds significantly to bone that is present at the time of administration. ZA quantification indicated that delayed administration significantly increased the uptake efficiency in the callus. Histological and microCT analysis showed that ZA treated calluses had a distinctive internal structure consisting of an intricate network of retained trabecular bone. CONCLUSIONS: The timing of a single systemic dose of ZA plays an important role in the modulation of callus properties in this rat fracture model; delaying the single dose produces a larger and stronger callus. 相似文献
65.
Mario Sénéchal Isabelle Lemieux Isabel Beucler Gerard Drobinski Sylvie Cormont Michelle Dubois Iradj Gandjbakhch Jean-Pierre Després Richard Dorent 《The Journal of heart and lung transplantation》2005,24(7):819-826
BACKGROUND: This study evaluated the prevalence of the atherogenic metabolic triad and the hypothesis that waist circumference and fasting triglyceride concentrations could be used as screening tools for identification of the atherogenic metabolic triad in a population of heart transplant men. It also evaluated the relationship between the atherogenic metabolic triad and coronary artery disease (CAD). METHODS: In the study group of 83 consecutive male heart transplant patients having their routine annual coronarography, 23 patients (28%) were characterized by the atherogenic metabolic triad defined by the presence of elevated fasting insulin and apolipoprotein B concentrations and by small low-density lipoprotein (LDL) particles. RESULTS: Seventy-seven per cent of patients with waist circumference values >/= 90 cm and with elevated triglyceride levels (>/=2.0 mmol/liter) were characterized by this atherogenic metabolic triad. Patients with the atherogenic metabolic triad were at markedly increased risk of CAD (odds ratio of 25.3, 95% CI: 1.11-577.3, p < 0.04) compared to heart transplant patients without the atherogenic metabolic triad. CONCLUSIONS: About 30% of heart transplant patients showed the features of the atherogenic metabolic triad. Measurement and interpretation of waist circumference and fasting triglycerides could be used among heart transplant patients to early identify men characterized by the presence of elevated fasting insulin and apolipoprotein B concentrations and small LDL particles. The presence of the atherogenic metabolic triad identified patients at high risk of CAD even in the heart transplant population. 相似文献
66.
急性心肌梗死患者出现束支传导阻滞(BBB)被认为与预后差有关。这种观点在血管成形术时代是否正确尚不清楚。本研究旨在评估采用直接血管成形术治疗的急性心肌梗死伴BBB患者的预后。评估了急性心肌梗死直接血管成形术试验中3053例接受急诊导管术的患者。将入院心电图存在左束支传导阻滞的患者(LBBB,n=48,1.6%)与右束支传导阻滞患者(RBBB,n=95,3.1%)或无BBB患者(n=2910,95.3%)进行比较。具有BBB的患者年龄较大,更多见糖尿病、外周血管疾病和曾行冠状动脉搭桥术,射血分数较低,多支血管病变多见。 相似文献
67.
68.
69.
70.